124 related articles for article (PubMed ID: 24079174)
21. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues.
Roman BI; Ryck TD; Dierickx L; Vanhoecke BW; Katritzky AR; Bracke M; Stevens CV
Bioorg Med Chem; 2012 Aug; 20(15):4812-9. PubMed ID: 22743088
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
[TBL] [Abstract][Full Text] [Related]
23. The products of the reaction between 6-amine-1,3-dimethyl uracil and bis-chalcones induce cytotoxicity with massive vacuolation in HeLa cervical cancer cell line.
Solano JD; González-Sánchez I; Cerbón MA; Guzmán Á; Martínez-Urbina MA; Vilchis-Reyes MA; Martínez-Zuñiga EC; Alvarado C; Quintero A; Díaz E
Eur J Med Chem; 2013 Feb; 60():350-9. PubMed ID: 23314048
[TBL] [Abstract][Full Text] [Related]
24. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
Zhou J; Geng G; Batist G; Wu JH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1183-6. PubMed ID: 19138519
[TBL] [Abstract][Full Text] [Related]
25. Antiprotozoal activity of chloroquinoline based chalcones.
Hayat F; Moseley E; Salahuddin A; Van Zyl RL; Azam A
Eur J Med Chem; 2011 May; 46(5):1897-905. PubMed ID: 21377771
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
28. Chemistry and pharmacology of oxyprenylated secondary plant metabolites.
Epifano F; Genovese S; Menghini L; Curini M
Phytochemistry; 2007 Apr; 68(7):939-53. PubMed ID: 17343885
[TBL] [Abstract][Full Text] [Related]
29. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents.
Rostom SA; Badr MH; Abd El Razik HA; Ashour HM; Abdel Wahab AE
Arch Pharm (Weinheim); 2011 Sep; 344(9):572-87. PubMed ID: 21755528
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities.
Rao GV; Swamy BN; Chandregowda V; Reddy GC
Eur J Med Chem; 2009 May; 44(5):2239-45. PubMed ID: 18603336
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure activity relationship and mode of action of 3-substitutedphenyl-1-(2,2,8,8-tetramethyl-3,4,9,10-tetrahydro-2H,8H-pyrano[2,3-f]chromen-6-yl)-propenones as novel anticancer agents in human leukaemia HL-60 cells.
Murthy YL; Suhasini KP; Pathania AS; Bhushan S; Nagendra Sastry Y
Eur J Med Chem; 2013 Apr; 62():545-55. PubMed ID: 23419739
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
34. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.
Mielcke TR; Mascarello A; Filippi-Chiela E; Zanin RF; Lenz G; Leal PC; Chiaradia LD; Yunes RA; Nunes RJ; Battastini AM; Morrone FB; Campos MM
Eur J Med Chem; 2012 Feb; 48():255-64. PubMed ID: 22209415
[TBL] [Abstract][Full Text] [Related]
35. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
[TBL] [Abstract][Full Text] [Related]
36. DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
Dalla Via L; Gia O; Chiarelotto G; Ferlin MG
Eur J Med Chem; 2009 Jul; 44(7):2854-61. PubMed ID: 19155103
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.
Bandgar BP; Gawande SS
Bioorg Med Chem; 2010 Mar; 18(5):2060-5. PubMed ID: 20138527
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-tumor activity of novel aminomethylated derivatives of isoliquiritigenin.
Fu H; Zhang Y; Wang X; Han Y; Peng X; Efferth T; Fu Y
Molecules; 2014 Oct; 19(11):17715-26. PubMed ID: 25365296
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]